NCT07451366Completed
Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Source: ClinicalTrials.gov · Last updated 5 Nov 2026
Brief summary (registry, in English)
Our study will assess the prevalence of obesity among patients with (MASLD) and to evaluate the characteristics of lean MAFLD patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 28 Feb 2026
- Start date
- 1 Jul 2026
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- Assiut University
- Diseases
- Obesity, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07451366
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 1 Jul 2026 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Fatty liver patients on treatment by statin derivatives or other medications.
Other illness
- Presence of malignancy
Age
- Patients aged ≤18 years old.
Other
- Pregnancy.
- Type I DM.
- Fatty liver patients undergone bariatric surgerie
Who the study is looking for
- All patients aged \>18 years old
- diagnosed as fatty liver based on clinical examination, laboratory investigations and imaging techniques
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assiut University Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.